Abstract:BACKGROUNDMesenchymal stem cells (MSCs) have been used in liver transplantation and have certain effects in alleviating liver ischemia-reperfusion injury (IRI) and regulating immune rejection. However, some studies have indicated that the effects of MSCs are not very significant. Therefore, approaches that enable MSCs to exert significant and stable therapeutic effects are worth further study. AIMTo enhance the therapeutic potential of human menstrual blood-derived stromal cells (MenSCs) in the mouse liver ischemia-reperfusion (I/R) model via interferon-gamma (IFN-gamma) priming. METHODSApoptosis was analyzed by flow cytometry to evaluate the safety of IFN-gamma priming, and indoleamine 2,3-dioxygenase (IDO) levels were measured by quantitative real-time reverse transcription polymerase chain reaction, western blotting, and ELISA to evaluate the efficacy of IFN-gamma priming. In vivo, the liver I/R model was established in male C57/BL mice, hematoxylin and eosin and TUNEL staining was performed and serum liver enzyme levels were measured to assess the degree of liver injury, and regulatory T cell (Treg) numbers in spleens were determined by flow cytometry to assess immune tolerance potential. Metabolomics analysis was conducted to elucidate the potential mechanism underlying the regulatory effects of primed MenSCs. In vitro, we established a hypoxia/reoxygenation (H/R) model and analyzed apoptosis by flow cytometry to investigate the mechanism through which primed MenSCs inhibit apoptosis. Transmission electron microscopy, western blotting, and immunofluorescence were used to analyze autophagy levels. RESULTSIFN-gamma-primed MenSCs secreted higher levels of IDO, attenuated liver injury, and increased Treg numbers in the mouse spleens to greater degrees than untreated MenSCs. Metabolomics and autophagy analyses proved that primed MenSCs more strongly induced autophagy in the mouse livers. In the H/R model, autophagy inhibitors increased the level of H/R-induced apoptosis, indicating that autophagy exerted protective effects. In addition, primed MenSCs decreased the level of H/R-induced apoptosis via IDO and autophagy. Further rescue experiments proved that IDO enhanced the protective autophagy by inhibiting the mammalian target of rapamycin (mTOR) pathway and activating the AMPK pathway. CONCLUSIONIFN-gamma-primed MenSCs exerted better therapeutic effects in the liver I/R model by secreting higher IDO levels. MenSCs and IDO activated the AMPK-mTOR-autophagy axis to reduce IRI, and IDO increased Treg numbers in the spleen and enhanced the MenSC-mediated induction of immune tolerance. Our study suggests that IFN-gamma-primed MenSCs may be a novel and superior MSC product for liver transplantation in the future.

[Role of IFN-γ in the Regulation of Murine Hemopoiesis].

The Regulatory Role of IFN-γ on the Proliferation and Differentiation of Hematopoietic Stem and Progenitor Cells

IFNgamma Induces Expansion of Hematopoietic Progenitor Cells (36.9)

Hemgn Protects Hematopoietic Stem and Progenitor Cells Against Transplantation Stress Through Negatively Regulating IFN‐ γ Signaling

[Effects of Intrasplenic Transplantation of IL-18 Gene-Modified Fetal Hepatocytes on Mouse Immune Function]

Interferon Gamma Inhibits the Differentiation of Mouse Adult Liver and Bone Marrow Hematopoietic Stem Cells by Inhibiting the Activation of Notch Signaling

Brief Report: Interferon-Gamma Induces Expansion of Lin(-)Sca-1(+)C-Kit(+) Cells

[Influence of Mouse Genetic Engineering Regulatory T Cells Infusion on Post-Allogeneic Bone Marrow Transplantation Acute Graft-Versus-host Disease in Mice].

Dichotomous Role of Interferon-γ in Allogeneic Bone Marrow Transplant

Lack of IFN-γ Receptor Signaling Inhibits Graft-versus-Host Disease by Potentiating Regulatory T Cell Expansion and Conversion.

Interferon- priming enhances the therapeutic effects of menstrual blood-derived stromal cells in a mouse liver ischemia-reperfusion model

Paradoxical Effects Of Ifn-Gamma In Graft-Versus-Host Disease Reflect Promotion Of Lymphohematopoietic Graft-Versus-Host Reactions And Inhibition Of Epithelial Tissue Injury

[Effects of IFN-γ Treatment on Biological Characteristics and Functions of Dendritic Cells].

IFN-γ Promotes Graft-Versus-leukemia Effects Without Directly Interacting with Leukemia Cells in Mice after Allogeneic Hematopoietic Cell Transplantation.

IFN-γ Differentially Regulates Subsets of Gr-1(+)CD11b(+) Myeloid Cells in Chronic Inflammation.

Negative Regulator of Stem Cell-Based Bone Marrow Regeneration

Macrophage-Lineage Cells Negatively Regulate the Hematopoietic Stem Cell Pool in Response to Interferon Gamma at Steady State and During Infection.

Early application of IFNγ mediated the persistence of HBV in an HBV mouse model

Impairment of Hepatic NK Cell Development in IFN-γ Deficient Mice

Natural Killer Cells-Produced IFN-γ Improves Bone Marrow-Derived Hepatocytes Regeneration in Murine Liver Failure Model

A Critical Role of IFNγ in Priming MSC-mediated Suppression of T Cell Proliferation Through Up-Regulation of B7-H1